- UroToday Home
- Beyond the Abstracts
- Urologic Oncology
Prostate Cancer
Prostate Cancer in Australia: The Paradox of Falling Localized Disease Rates yet Continued Mortality Reduction - Beyond the Abstract
October 19, 2022
Post-Diagnostic Health Behaviour Scores in Relation to Fatal Prostate Cancer - Beyond the Abstract
October 13, 2022
Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer - Beyond the Abstract
October 13, 2022
Association of Prostate Volume and the Incidence of Prostate Cancer Determined on MRI-Fusion Biopsy: A systemic Review - Beyond the Abstract
October 6, 2022
The Future of PSMA PET and WB MRI as Next-Generation Imaging Tools in Prostate Cancer - Beyond the Abstract
September 28, 2022
Approaches to Bladder Drainage After MRI-Guided Transurethral Ultrasound Ablation (TULSA) for Prostate Cancer - Beyond the Abstract
September 14, 2022
Future Directions in Systemic Treatment of Metastatic Hormone-Sensitive Prostate Cancer - Beyond the Abstract
September 9, 2022
Association Between Alcohol Intake and Prostate Specific Antigen Screening: Results from a National Behavioral Survey - Beyond the Abstract
September 8, 2022
Tumor Genomic Testing for >4000 Men with Metastatic Castration-Resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib) - Beyond the Abstract
September 6, 2022
Understanding the Mechanisms of Exercise as a Medicine to Increase Survival of Men with Prostate Cancer - Beyond the Abstract
August 22, 2022